Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of COVID-19 vaccination strategies with a delayed second dose
Seyed M. Moghadas, Thomas N. Vilches, Kevin Zhang, et al.
PLoS Biology (2021) Vol. 19, Iss. 4, pp. e3001211-e3001211
Open Access | Times Cited: 141

Showing 26-50 of 141 citing articles:

Estimating the impact of interventions against COVID-19: From lockdown to vaccination
James Thompson, Stephen Wattam
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0261330-e0261330
Open Access | Times Cited: 33
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval
Brian Grunau, Michael Asamoah-Boaheng, Pascal M. Lavoie, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e888-e891
Open Access | Times Cited: 32
A simulation-deep reinforcement learning (SiRL) approach for epidemic control optimization
Sabah Bushaj, Xuecheng Yin, Arjeta Beqiri, et al.
Annals of Operations Research (2022) Vol. 328, Iss. 1, pp. 245-277
Open Access | Times Cited: 25
Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity
Michael Asamoah-Boaheng, David A. Goldfarb, Martin A. Prusinkiewicz, et al.
Cureus (2023)
Open Access | Times Cited: 15
Vaccine Allocation and Distribution: A Review with a Focus on Quantitative Methodologies and Application to Equity, Hesitancy, and COVID-19 Pandemic
Emanuele Blasioli, Bahareh Mansouri, Srinivas Subramanya Tamvada, et al.
Operations Research Forum (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 15
Protect or prevent? A practicable framework for the dilemmas of COVID-19 vaccine prioritization
Raghu Arghal, Harvey Rubin, Shirin Saeedi Bidokhti, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316294-e0316294
Open Access
The effect of COVID vaccination timing on the seroprevalence of IgG antibodies: evidence from the Guayas region of Ecuador
Aurora Malacatus-Arboleda, Erick Barbotó-Ramírez, Gonzalo E. Sánchez, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Improved antibody breadth with an extended primary dose interval of COVID-19 vaccine is overcome by boosters
J. Ahmed, Samantha J. Krosta, M. Reimer, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine
Erin Kirwin, Ellen Rafferty, Kate Harback, et al.
PharmacoEconomics (2021) Vol. 39, Iss. 9, pp. 1059-1073
Open Access | Times Cited: 29
Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
Franziska Günl, Angeles Mecate‐Zambrano, Selina Rehländer, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1052-1052
Open Access | Times Cited: 28
Study of optimal vaccination strategies for early COVID-19 pandemic using an age-structured mathematical model: A case study of the USA
Giulia Luebben, Gilberto González‐Parra, Bishop Cervantes
Mathematical Biosciences & Engineering (2023) Vol. 20, Iss. 6, pp. 10828-10865
Open Access | Times Cited: 12
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults
Christina A. Rostad, Robert L. Atmar, Emmanuel B. Walter, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. 6, pp. 1757-1768
Closed Access | Times Cited: 3
Optimizing global COVID-19 vaccine allocation: An agent-based computational model of 148 countries
Qingfeng Li, Y. Huang
PLoS Computational Biology (2022) Vol. 18, Iss. 9, pp. e1010463-e1010463
Open Access | Times Cited: 18
Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2
Leonardo Souto Ferreira, Otavio Canton, Rafael Lopes Paixão da Silva, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 3, pp. e1009978-e1009978
Open Access | Times Cited: 17
Comparison between one and two dose SARS-CoV-2 vaccine prioritization for a fixed number of vaccine doses
Edward M. Hill, Matt J. Keeling
Journal of The Royal Society Interface (2021) Vol. 18, Iss. 182
Open Access | Times Cited: 22
Efficacy and Safety of COVID-19 Vaccines—An Update
Eshani Sharma, Sraddha Revinipati, Saisha Bhandari, et al.
Diseases (2022) Vol. 10, Iss. 4, pp. 112-112
Open Access | Times Cited: 15
The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic
Sylvia Annabel Dass, Venugopal Balakrishnan, Norsyahida Arifin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization
Carlos King Ho Wong, Xi Xiong, Kristy T. K. Lau, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil
Leonardo Souto Ferreira, Gabriel Berg de Almeida, Marcelo Eduardo Borges, et al.
Vaccine (2022) Vol. 40, Iss. 46, pp. 6616-6624
Open Access | Times Cited: 14
Developing a national pandemic vaccination calendar under supply uncertainty
Sırma Karakaya, Burcu Balcik
Omega (2023) Vol. 124, pp. 103001-103001
Closed Access | Times Cited: 7
Covid19Vaxplorer: A free, online, user-friendly COVID-19 vaccine allocation comparison tool
Imelda Trejo, Pei-Yao Hung, Laura Matrajt
PLOS Global Public Health (2024) Vol. 4, Iss. 1, pp. e0002136-e0002136
Open Access | Times Cited: 2
Estimation of trajectory of protective efficacy in infectious disease prevention trials using recurrent event times
Yin Bun Cheung, Xiangmei Ma, Kwok Fai Lam, et al.
Statistics in Medicine (2024) Vol. 43, Iss. 9, pp. 1759-1773
Open Access | Times Cited: 2
Novel multi-cluster workflow system to support real-time HPC-enabled epidemic science: Investigating the impact of vaccine acceptance on COVID-19 spread
Parantapa Bhattacharya, Dustin Machi, Jiangzhuo Chen, et al.
Journal of Parallel and Distributed Computing (2024) Vol. 191, pp. 104899-104899
Closed Access | Times Cited: 2
Heterogeneous joint vaccine allocation and quarantine restriction planning under uncertainty: The COVID-19 pandemic
Mehrdad Mohammadi, Erfan Asgari, Maryam Karimi Mamaghan, et al.
Omega (2024) Vol. 128, pp. 103133-103133
Open Access | Times Cited: 2
Early mathematical models of COVID-19 vaccination in high-income countries: a systematic review
Eleanor Burch, S A Khan, Jack Stone, et al.
Public Health (2024) Vol. 236, pp. 207-215
Open Access | Times Cited: 2

Scroll to top